Abstract
The authors of the original article “Evaluation of METase-Pemetrexed-Loaded PEG-PLGA Nanoparticles Modified with Anti-CD133-scFV for Treatment of Gastric Carcinoma” (Biosci Rep (2018) 38(1), DOI: 10.1042/BSR20171001) would like to correct Figure 2C. During the authors' figure build of Figure 2C, the migration images in the “CD133-” group and the “CD133+” group had been switched. The authors declare that these corrections do not change the results or conclusions of their paper, and would like to apologize for any inconvenience caused. All of the authors have approved the correction. The correct version of Figure 2 is presented here.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
